Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CRHR1 | P34998 | 5/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.32 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601480 | 0.94 | FLT3 (0.34) | FLT3CYP1A2CYP2A6KDM4EMAPT | |
| SCHEMBL24601528 | 0.92 | NTRK1 (0.39) | FLT3KDM4EMAPTNTRK1ALKBH5 | |
| SCHEMBL24601459 | 0.90 | CYP1A2 (0.40) | FLT3CYP1A2CYP2A6KDM4EMAPT | |
| SCHEMBL24601481 | 0.85 | NTRK1 (0.39) | FLT3KDM4EMAPTNTRK1ALKBH5 | |
| SCHEMBL24601592 | 0.85 | CYP1A2 (0.38) | FLT3CYP1A2CYP2A6KDM4EMAPT | |
| SCHEMBL24601615 | 0.83 | CYP1A2 (0.39) | FLT3CYP1A2CYP2A6KDM4EMAPT | |
| SCHEMBL24601313 | 0.83 | CYP1A2 (0.33) | CYP1A2CYP2A6MAPT | |
| SCHEMBL24601649 | 0.82 | HSD17B10 (0.36) | FLT3KDM4EMAPT | |
| SCHEMBL24601430 | 0.82 | HSD17B10 (0.36) | FLT3KDM4EMAPT | |
| SCHEMBL22178500 | 0.82 | NR3C1 (0.41) | CYP1A2KDM4EMAPTALKBH5FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NCL, NOC2L, NOLC1 | FLT3 1779/4885CYP1A2 4681/4885CYP2A6 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.